CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Body Composition Predicts Survival in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization

Neehar D. Parikh, Peng Zhang, Amit G. Singal, Brian A. Derstine, Venkat Krishnamurthy, Pranab Barman, Akbar K. Waljee, Grace L. Su

Cancer Research and Treatment. 2018;50(2):530-537. Published online 2017 June 1 DOI: https://doi.org/10.4143/crt.2017.156

Body Composition Predicts Survival in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization

Neehar D. Parikh, Peng Zhang, Amit G. Singal, Brian A. Derstine, Venkat Krishnamurthy, Pranab Barman, Akbar K. Waljee, Grace L. Su

Cancer Research and Treatment. 2018;50(2):530-537

Link1

Link2 Link3

Survival of patients with intermediate stage hepatocellular carcinoma treated with superselective transarterial chemoembolization using doxorubicin-loaded DC Bead under cone-beam computed tomography control

Peter Popovic, Borut Stabuc, Rado Jansa, Manca Garbajs

Radiology and Oncology. 2016;50(4):

Link1 Link2

An inflammation-based prognostic index predicts survival advantage after transarterial chemoembolization in hepatocellular carcinoma

David J. Pinato, Rohini Sharma

Translational Research. 2012;160(2):146-152

Link1 Link2

Survival Rates in Hepatocellular Carcinoma Patient Treated by Transarterial Chemoembolization: Comparison withOperable and Inoperable Cases

Tae Yong Moon

Journal of the Korean Radiological Society. 1998;38(4):629

Link1

Nonresectable Hepatocellular Carcinoma: Long-term Toxicity in Patients Treated with Transarterial Chemoembolization—Single-Center Experience

T.G. Walker

Yearbook of Diagnostic Radiology. 2009;2009:212-214

Link1 Link2

Hypothyroidism in patients with hepatocellular carcinoma treated by transarterial chemoembolization

Felix Flohr, Jan Harder, Jochen Seufert, Hubert E. Blum, Hans C. Spangenberg

Hepatology. 2008;47(6):2144-2144

Link1

Obesity conveys poor outcome in patients with hepatocellular carcinoma treated by transarterial chemoembolization

S.E. Wu, H.W. Charles, J.S. Park, A.S. Goldenberg, A.R. Deipolyi

Diagnostic and Interventional Imaging. 2017;98(1):37-42

Link1 Link2

Relationship between overall survival and time to progression after transarterial chemoembolization therapy in patients with hepatocellular carcinoma

T. Arizumi, K. Ueshima, M. Kudo

Journal of Hepatology. 2017;66(1):S620

Link1 Link2

Transarterial Chemoembolization Can Be Safely Performed in Patients with Hepatocellular Carcinoma Invading the Main Portal Vein and May Improve the Overall Survival

T.G. Walker

Yearbook of Diagnostic Radiology. 2011;2011:240-243

Link1 Link2

Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma

Johannes Baur, Christian Ritter, Christoph-Thomas Germer, Ingo Klein, Ralph Kickuth, Ulrich Steger

Hepatic Medicine: Evidence and Research. 2016;69

Link1

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.